BKEMV 300 mg/30mL
eculizumab-aeeb · INJECTION, SOLUTION, CONCENTRATE · Amgen Inc
No Recall History
Plain English
BKEMV is a injection, solution, concentrate containing eculizumab-aeeb at 300 mg/30mL, taken intravenous. Manufactured by Amgen Inc.
Key Facts
- Brand Name
- BKEMV
- Generic Name
- eculizumab-aeeb
- NDC Code (Product)
55513-180- Manufacturer
- Amgen Inc
- Strength
- 300 mg/30mL
- Dosage Form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761333
- Drug Class
- Complement Inhibitor [EPC]
- Marketing Start
- 03/01/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is BKEMV used for?
BKEMV contains eculizumab-aeeb. It is a injection, solution, concentrate taken intravenous. Consult your doctor for specific uses.
Is BKEMV a controlled substance?
BKEMV is not classified as a controlled substance by the DEA.
What is the generic name for BKEMV?
The generic name for BKEMV is eculizumab-aeeb. There are no other listed brand versions of eculizumab-aeeb.
What is the NDC code for BKEMV 300 mg/30mL?
The NDC (National Drug Code) for BKEMV 300 mg/30mL is 55513-180, listed by Amgen Inc.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)